Enhanced community health worker program for cardiovascular disease management
PhillyCEAL: Addressing Disparities in Chronic Disease Self-management Through an Enhanced Community Health Worker Program
This study is testing a new program that helps people with heart disease in Philadelphia learn to manage their health better by providing extra support from community health workers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 35 Years to 75 Years |
| Sex | All |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT06732102 on ClinicalTrials.gov |
What this trial studies
This study evaluates an enhanced community health worker (CHW) program aimed at improving cardiovascular disease (CVD) self-management skills among underserved populations in Philadelphia. Participants aged 35-75 with CVD risk factors and unmet social needs will receive the DECIDE+ intervention, which includes bi-weekly group sessions and CHW consultations, or continue with standard CHW services. The study employs a Type 1 Hybrid Effectiveness-Implementation Design and aims to recruit 500 residents to assess improvements in health behaviors and resolution of social needs. The primary outcome will be measured using the Self-care of Chronic Illness Inventory Maintenance scale.
Who should consider this trial
Good fit: Ideal candidates are Philadelphia residents aged 35-75 with one or more CVD risk factors and unmet social needs.
Not a fit: Patients who do not reside in Philadelphia or do not have CVD-related chronic conditions will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance self-management skills for cardiovascular health among underserved populations, potentially reducing CVD-related morbidity and mortality.
How similar studies have performed: Other studies have shown success with community health worker interventions in managing chronic diseases, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Reside in Philadelphia * Be between 35 and 75 years of age (inclusive) * Self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions: 1. Pre-diabetes 2. Diabetes 3. Hypertension 4. Hyperlipidemia/ high cholesterol) 5. BMI \>=30. * Have completed an initial visit with a CEO CHW * Have one or more unmet social needs identified in the CEO Intake Form in the following areas: 1. Housing Stability, 2. Food security, 3. Transportation to medical appointments and/or work, 4. Employment, 5. Household utilities, 6. Healthcare access, 7. Health literacy, and 8. Social support. * Willing to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment. Exclusion Criteria: * Does not reside in Philadelphia * Not between 35 and 75 years of age (inclusive) * Does not self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions: 1. Pre-diabetes 2. Diabetes 3. Hypertension 4. Hyperlipidemia/ high cholesterol) 5. BMI \>=30. * Has not completed an initial visit with a CEO CHW * Does not have one or more unmet social needs identified in the CEO Intake Form in the following areas: 1. Housing Stability, 2. Food security, 3. Transportation to medical appointments and/or work, employment, 4. Household utilities, 5. Healthcare access, 6. Health literacy, and 7. Social support. * Unwilling to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.
Where this trial is running
Philadelphia, Pennsylvania
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Jose Bauermeister, MPH, PhD — University of Pennsylvania
- Study coordinator: Jose Bauermeister, MPH, PhD
- Email: phillyceal@nursing.upenn.edu
- Phone: 215-898-9993
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.